OTCMKTS:SEOVFSernova Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.19 0.00 (-2.44 %) (As of 07/14/2020 04:00 PM ET) Add Compare Share Today's Range$0.18Now: $0.19▼$0.1950-Day Range$0.14MA: $0.19▼$0.2352-Week Range$0.06Now: $0.19▼$0.25Volume7,475 shsAverage Volume28,189 shsMarket Capitalization$36.92 millionP/E RatioN/ADividend YieldN/ABeta1.23 ProfileAdvanced ChartCompetitorsEarningsHeadlinesSocial Media Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch and associated technologies, including therapeutic cells and local immune protection. The company is developing a Cell Pouch system that is in Phase I/II clinical trial for the treatment of type-1 diabetes. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells for the treatment of chronic diseases, such as hemophilia A and thyroid diseases. Sernova Corp. is headquartered in London, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Sernova. Previous Next 2.7 Community Rank Outperform VotesSernova has received 51 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSernova has received 43 “underperform” votes. (Add your “underperform” vote.)Community SentimentSernova has received 54.26% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote “Outperform” if you believe SEOVF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SEOVF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSernova does not currently pay a dividend.Dividend GrowthSernova does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sernova insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sernova is -6.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sernova is -6.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSernova has a P/B Ratio of 9.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SEOVF Previous Symbol CUSIPN/A CIKN/A Webwww.sernova.com Phone519-858-5184Debt Debt-to-Equity RatioN/A Current Ratio8.27 Quick Ratio8.27Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.02 per share Price / Book9.42Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-2,990,000.00 Net MarginsN/A Return on Equity-163.88% Return on Assets-143.91%Miscellaneous EmployeesN/A Outstanding Shares196,045,000Market Cap$36.92 million Next Earnings Date10/5/2020 (Estimated) OptionableNot Optionable OTC:SEOVF Rates by TradingView Receive SEOVF News and Ratings via Email Sign-up to receive the latest news and ratings for SEOVF and its competitors with MarketBeat's FREE daily newsletter. Sernova (OTCMKTS:SEOVF) Frequently Asked Questions How has Sernova's stock been impacted by COVID-19 (Coronavirus)? Sernova's stock was trading at $0.1092 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SEOVF stock has increased by 72.4% and is now trading at $0.1883. View which stocks have been most impacted by Coronavirus. When is Sernova's next earnings date? Sernova is scheduled to release its next quarterly earnings announcement on Monday, October 5th 2020. View our earnings forecast for Sernova. Has Sernova been receiving favorable news coverage? Press coverage about SEOVF stock has been trending extremely negative on Wednesday, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sernova earned a media sentiment score of -4.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the company's share price in the near future. View the latest news about Sernova. Who are some of Sernova's key competitors? Some companies that are related to Sernova include Scpharmaceuticals (SCPH), Aytu Bioscience (AYTU), Kindred Biosciences (KIN), Tyme Technologies (TYME), Galectin Therapeutics (GALT), Cerecor (CERC), vTv Therapeutics (VTVT), Evofem Biosciences (EVFM), Aquestive Therapeutics (AQST), Cyclerion Therapeutics (CYCN), Mustang Bio (MBIO), BIOFRONTERA AG/ADR (BFRA), Evelo Biosciences (EVLO), CELYAD SA/ADR (CYAD) and InflaRx (LUMO). View all competitors. Who are Sernova's key executives? Sernova's management team includes the following people: Dr. Philip M. Toleikis, Pres, CEO & DirectorMr. Sean P. Hodgins CPA, CA, (Illinois), Chief Financial OfficerMr. Douglas Maret, Chief Science Officer What is Sernova's stock symbol? Sernova trades on the OTCMKTS under the ticker symbol "SEOVF." How do I buy shares of Sernova? Shares of SEOVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sernova's stock price today? One share of SEOVF stock can currently be purchased for approximately $0.19. How big of a company is Sernova? Sernova has a market capitalization of $36.92 million. What is Sernova's official website? The official website for Sernova is www.sernova.com. How can I contact Sernova? Sernova's mailing address is 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8. The company can be reached via phone at 519-858-5184 or via email at [email protected] This page was last updated on 7/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
